This month`s newletter from the HCV Advocate website includes reports from the NEJM (New England Journal of Medicine) and EASL 2014 (European Association for the Study of the Liver) on the latest drug developments, as well as other articles of interest.
This month`s newletter from the HCV Advocate website includes reports from the NEJM (New England Journal of Medicine) and EASL 2014 (European Association for the Study of the Liver) on the latest drug developments, as well as other articles of interest.
http://www.hcvadvocate.org/news/newsLetter/2014/advocate0514.html